Given their life-saving potential, newborn screenings should not be seen as optional but as a fundamental part of postnatal ...

PKU is a rare genetic disease that manifests at birth and is marked by an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods. Left untreated ...

The Argentina inborn errors of protein metabolism (IEPM) market was valued at US$ 268.2 million in 2023 and is expected to achieve a market valuation of US$ 664.0 million by 2032. This impressive ...

PKU is a genetic disease that manifests at birth and results from an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods. Left untreated, high levels of ...

Market OverviewThe global Newborn Screening Market is valued at USD 3.44 Billion in 2024 and is projected to reach a value of ...